Capped: Oximeter, 4 other devices to become cheaper
Capped: Oximeter, 4 other devices to become cheaper
Agencies / Updated: Jul 25, 2021, 06:00 IST
Following the capping of prices by the
National Pharmaceutical Pricing Authority (NPPA), 91 per cent brands of five medical devices reported downward revision of prices up to 88 per cent, informed the
Ministry of Chemicals and Fertilizers on Saturday.
The Centre has capped the Trade Margin for five medical devices -
Pulse Oximeter, Blood Pressure Monitoring Machine,
Nebulizer,
MRP was effective from July 20, 2021.
“The margin was capped up to 70 per cent on Price to Distributor (PTD) level. Pursuant there to, a total of 684 products/brands of these medical devices have been reported as on July 23, 2021, and 620 products/brands (91 per cent) have reported downward revision of MRP,” the ministry said.
GST s anti-profiteering body calls for prioritising consumer complaints on rate cut benefit
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.
Government slashes Remdesivir MRP by half, with retro-effect
indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.
Drug pricing regulator NPPA undertook necessary steps to ensure availability of life saving essential medicines across the country during the COVID-19 pandemic, the Economic Survey said on Friday. Drug prices in India are regulated to ensure continued availability and affordability of essential medicines with improved access to consumers, it added. National Pharmaceutical Pricing Authority (NPPA). has played an active role in addressing the exigencies arising out of COVID-19 pandemic and undertook necessary measures to ensure continued availability of life saving essential medicines throughout the country, the survey said. The regulator invoked extraordinary powers in public interest to ensure that policy enhances access to life saving drugs like Heparin as well as medical oxygen, it added.